AbbVie, Inc. (ABBV)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
-22.7%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
-17.99%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
-15.67%
FV Accuracy
8 Hits (16.33% Hit Rate)
FV Avg. Distance
-13.1%
About
CEO
Richard A. Gonzalez
Employees
30,000
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
North Chicago
Exchange
New York Stock Exchange
Website
http://www.abbvie.comSummary Stats
Market Cap
266B
Revenue
56.7B
Net Income
12.4B
EPS
$6.98
Price-to-Earnings
21.57
Price-to-Book
16.34
Debt-to-Equity
7.8
News
Analyst Ratings
Price targets projected by 20 analysts
High
$127.00
Average
$111.45
Low
$97.00
Ratings calculated by 22 analysts
Buy
16
Hold
6
Sell
0
Last Dividend
Amount
$1.41
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Above by $0.02
$3.16 +0.6%
3.14
2.95
Up 7%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--